Several companies, including DIAGENS-B (02526), TONGRENTANGCARE (02667), EXTREME VISION (06636), HUAYAN ROBOTICS (01021), and EPIWORLD (02726), are currently undergoing their initial public offering subscriptions. As of March 20, brokerages such as Futu Securities and Phillip Securities have provided margin financing of HK$445 million for DIAGENS-B, resulting in an oversubscription of more than 4.94 times. For TONGRENTANGCARE, margin lending reached HK$426 million, with oversubscription exceeding 4.74 times. EXTREME VISION attracted HK$608 million in margin financing, leading to an oversubscription of over 24.34 times. HUAYAN ROBOTICS saw the highest margin financing at HK$1.877 billion, with oversubscription surpassing 27.33 times. EPIWORLD received HK$618 million in margin loans, achieving an oversubscription of more than 3.77 times.